Boston Millennia Partners
Boston Millennia Partners Congratulates PreCision Dermatology Management on $500 Million Sale to Valeant Pharmaceuticals International
07.07.14
With the receipt of Hart-Scott-Rodino clearance, the previously announced acquisition of Precision Dermatology by Valeant Pharmaceuticals International, Inc. for $500 million, closed July 7, 2014. Read Full Release
CardioMEMS
Boston Millennia Partners announces the sale of its portfolio company CardioMEMS to St. Jude Medical
06.03.14
Boston Millennia Partners is pleased to announce that St. Jude Medical (NYSE: STJ) has acquired the remaining 81 percent of CardioMEMS, Inc. it does not own for $375 million dollars. Read Full Release
MedAptus
Boston Millennia Portfolio Company, MedAptus, Announces First Coast Cardiovascular Institute Implemented Professional Charge Capture
06.10.14
First Coast Cardiovascular Institute (FCCI) has successfully implemented MedAptus’ Professional Charge Capture application and is experiencing significant improvement in efficiency. FCCI chose MedAptus based on functionality and strong track record of success in multi-specialty environment. Read Full Release
MedAptus
Boston Millennia Portfolio Company, MedAptus, Enters into a Strategic Marketing Agreement with BESLER Consulting
04.24.14
MedAptus has entered into a strategic marketing agreement with BESLER Consulting, a leading provider of comprehensive revenue integrity services to healthcare organizations. Under the agreement, MedAptus and BESLER will promote each other’s healthcare services to their clients. Read Full Release
MedAptus
Boston Millennia Portfolio Company, Medaptus, Announces Methodist Healthcare Deploys MedAptus to Streamline Hospital-Based Charge Capture
03.26.14
Methodist Healthcare has implemented Medaptus’ Professional Charge Capture (Pro) solution to re-engineer paper-based processes for inpatient coding and billing. Methodist chose the MedAptus software based on ease-of-use, support for team care and robust real-time reconciliation capabilities. Read Full Release
MedAptus
Boston Millennia Portfolio Company, MedAptus®, Announces Availability of Risk Severity Toolkit to Assist with HCC Coding
02.11.14
MedAptus® announces that it has released a Risk Severity Toolkit to help provider groups measure and manage the disease burden of patients covered under risk-based contracts. Read Full Release
PAREXEL International
PAREXEL International Reports Second Quarter Fiscal Year 2014 Results
01.29.14
PAREXEL International Second Quarter Fiscal Year 2014 Results were announced and for the three months ended December 31, 2013 consolidated service revenue increased by 15.4% to $487.1 million. Read Full Release
Odyssey Logistics & Technology
Boston Millennia Portfolio Company, Odyssey Logistics & Technology, Inc., Announces Achievement of Double-Digit, Year-Over-Year Growth for 2013
02.04.14
Odyssey Logistics & Technology, a global supply chain logistics services provider, announced achieving double-digit, year-over-year growth of 32% in 2013. Read Full Release
MedAptus
Boston Millennia Portfolio Company, MedAptus®, Earns #1 Ranking from KLAS, Fourth Year in a Row
02.04.14
MedAptus® today announced that its Professional Charge Capture (Pro) solution has been named the Category Leader in the Mobile Data Systems segment in the “2013 Best in KLAS: Software & Services” report, marking the fourth consecutive year that MedAptus has received the distinction. Read Full Release
Boston Millennia Partners
Boston Millennia Partners Portfolio Company, PreCision Dermatology, Acquires Rights to Clindagel®
10.30.13
Onset Dermatologics, a PreCision Dermatology company and a leader in developing and commercializing prescription products for improving skin health, today announced the acquisition of Clindagel® from Galderma Laboratories. Read Full Release
MedAptus
Boston Millennia Portfolio Company, MedAptus, Featured in Recent HIStalk Blog
08.30.13
Ryan Secan, MD, MPH, Chief Medical Officer of MedAptus, Inc., a Boston Millennia portfolio company, was published on HIStalk for his comments on product development in health care technology. Read Full Release
Histogenics
Boston Millennia Portfolio Company, Histogenics Corp., Announces Key Additions to Management Team
08.20.13
Histogenics Corp. announced the addition of Stephen Kennedy as Senior Vice President of Manufacturing, Operations, and Supply Chain, and Vladimir Scerbin as Vice President of Clinical Affairs. Read Full Release
Nexidia, Inc.
Boston Millennia Portfolio Company, Nexidia, Recognized by Speech Technology Magazine
08.14.13
Nexidia was named Speech Analytics Market Winner for seventh consecutive year by Speech Technology Magazine. Read Full Release
Odyssey Logistics & Technology
Boston Millennia Portfolio Company, Odyssey Logistics, Recognized by Inbound Logistics Magazine
08.12.13
Odyssey Logistics has been named a 2013 Top 100 3PL Logistics Provider by Inbound Logistics Magazine for the ninth consecutive year. Read Full Release
PAREXEL International
PAREXEL International Reports Fourth Quarter And Fiscal Year 2013 Results
08.08.13
PAREXEL International Corp. (NASDAQ: PRXL) reported financial results for the fourth quarter and Fiscal Year 2013. For the three months ended June 30, 2013 consolidated service revenue increased by 18% to $463.1 million compared with $392.6 million in the prior year period. Read Full Release
PHT Corp
Boston Millennia Portfolio Company, PHT Corp., Names Steve Rosenberg Chief Operating Officer
06.24.13
PHT Corp., has named software industry veteran executive, Steve Rosenberg, Chief Operating Officer. Steve brings over 30 years of experience in operations, most recently as Vice President of Software and Services, Health Sciences Global Business Unit (HSGBU) at Oracle Corporation. Read Full Release
Collegium Pharmaceutical
Boston Millennia Portfolio Company, Collegium Pharmaceutical, Featured in Wall Street Journal
05.06.13
Collegium Pharmaceutical was featured in a Wall Street Journal article discussing the innovative technologies being developed in the painkiller market to make drugs more abuse-deterrent. Read Full Release
Histogenics
Boston Millennia Portfolio Company, Histogenics Corp., Announces Peter Greenleaf as CEO
06.10.13
Histogenics Corp. has announced the appointment of Peter Greenleaf to Chief Executive Officer. Mr. Greenleaf brings over 20 years of experience in the biotechnology industry, most recently as President of MedImmune, the worldwide biologics arm of AstraZeneca. Read Full Release
Odyssey Logistics & Technology
Boston Millennia Portfolio Company, Odyssey Logistics & Technology, Acquires Hawaii Intermodal Tank Transport
06.06.13
Odyssey Logistics & Technology, Inc. has announced the acquisition of Hawaii Intermodal Tank Transport, a leading operator of intermodal tanks with the largest fleet of refrigerated ISO Tanks exclusively used to move food-grade products. This marks Odyssey’s 10th acquisition since inception. Read Full Release
MedAptus
Boston Millennia Portfolio Company, MedAptus®, is Featured in an Article in the May Issue of Group Practice Journal
05.21.13
Boston Millennia Portfolio Company, MedAptus®, is featured in an article in Group Practice Journal, discussing the successful implementation of MedAptus® charge capture software across IHA, one of Michigan's largest group practices. Read Full Release